The Pharmaletter

One To Watch

Pharmacosmos

Pharmacosmos develops, manufactures and markets medicines for the treatment of iron deficiency anaemia in humans and animals.

Company Overview

Headquartered in Holbaek, Denmark, Pharmacosmos was founded in 1965 as a highly specialised company focused on carbohydrate chemistry and a global leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia. 

With companies in the UK, Ireland, Nordics, Germany, the USA, and China, as well as through partners, Pharmacosmos markets its products around the world. 



More Pharmacosmos news >